Trials / Conditions / Stage IV Inflammatory Breast Carcinoma
Stage IV Inflammatory Breast Carcinoma
3 registered clinical trials studyying Stage IV Inflammatory Breast Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer NCT02892734 | Northwestern University | Phase 2 |
| Terminated | Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery NCT02658812 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple- NCT02411656 | M.D. Anderson Cancer Center | Phase 2 |